Clinical Trial Update: Safety and Efficacy of Deucravacitinib in Participants With Moderate to Severe Ulcerative Colitis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety and efficacy of deucravacitinib in moderate to severe ulcerative colitis has been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Deucravacitinib (deucravacitinib)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Ulcerative Colitis | Phase 2 | Status: COMPLETED | Results posted: 2022-07-06